Childhood cancer incidence among specific Asian and Pacific Islander populations in the United States.
Asian and Pacific islander
childhood cancer
disparities
incidence
pediatric cancer
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 12 2020
15 12 2020
Historique:
received:
16
03
2020
revised:
21
05
2020
accepted:
30
05
2020
pubmed:
15
6
2020
medline:
17
4
2021
entrez:
15
6
2020
Statut:
ppublish
Résumé
Despite the vast genetic and environmental diversity in Asia, individuals of Asian and Pacific Islander (API) descent are often combined into a single group for epidemiologic analyses within the U.S. We used the Surveillance, Epidemiology and End Results (SEER) Detailed Asian/Pacific Islander Database to calculate incidence rates for discrete groups among children aged 0 to 19 years. Due to sample size constraints we pooled incidence among regional groups based on countries of origin: East Asians (Chinese, Japanese, Korean), Southeast (SE) Asians (Vietnamese, Laotian, Cambodian), Asian Indian/Pakistani, Oceanians (Guamanian, Samoan, Tongan) and Filipinos. Incidence rate ratios (IRR) and 95% confidence intervals (CI) were calculated comparing each API regional group to Non-Hispanic Whites (NHW) and East Asians. Finally, we calculated the correlation between incidence of cancer in specific API ethnicities in SEER and in originating countries in the Cancer Incidence in Five Continents. Incidence rates among API regional groups varied. Acute lymphoblastic leukemia (ALL) was lower in children of SE Asian descent (IRR 0.65, 95% CI 0.44, 0.96) compared to NHW. Acute myeloid leukemia (AML) was more common among children from Oceania compared to NHW (IRR 3.88, 95% CI 1.83, 8.22). East Asians had higher incidence rates than SE Asians but lower rates compared to children from Oceania. Correlation of some incidence rates between US-based API ethnicities and originating countries were similar. The variation observed in childhood cancer incidence patterns among API groups may indicate differences in underlying genetics and/or patterns of exposure.
Identifiants
pubmed: 32535909
doi: 10.1002/ijc.33153
pmc: PMC7736474
mid: NIHMS1642357
doi:
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3339-3348Subventions
Organisme : NCI NIH HHS
ID : T32 CA099936
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA163184
Pays : United States
Organisme : NCI NIH HHS
ID : T32CA163184
Pays : United States
Organisme : NIH HHS
ID : T32CA099936
Pays : United States
Informations de copyright
© 2020 UICC.
Références
Asian Pac J Cancer Prev. 2016;17(8):3989-95
pubmed: 27644650
BMC Cancer. 2015 Sep 03;15:613
pubmed: 26335225
J Gastroenterol Hepatol. 2018 Jan;33(1):111-120
pubmed: 28960448
Cancer. 2005 Apr 1;103(7):1457-67
pubmed: 15712273
Sci Rep. 2018 Jan 15;8(1):789
pubmed: 29335448
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604
pubmed: 31439937
MMWR Morb Mortal Wkly Rep. 2018 Jun 29;67(25):707-713
pubmed: 29953430
Ann Transl Med. 2015 Oct;3(17):250
pubmed: 26605296
Nat Commun. 2018 Jan 18;9(1):286
pubmed: 29348612
Eur J Cancer. 2009 Mar;45(5):747-55
pubmed: 19117750
J Clin Oncol. 2012 Mar 1;30(7):751-7
pubmed: 22291082
Science. 2019 Oct 18;366(6463):
pubmed: 31624180
Indian Pediatr. 2006 Feb;43(2):141-7
pubmed: 16528110
Int J Cancer. 2002 Dec 1;102(4):412-7
pubmed: 12402312
Paediatr Perinat Epidemiol. 2017 Nov;31(6):563-572
pubmed: 28940632
Cell. 2018 Mar 22;173(1):53-61.e9
pubmed: 29551270
JAMA Ophthalmol. 2014 Apr 1;132(4):478-83
pubmed: 24577366
J Natl Cancer Inst. 2013 May 15;105(10):733-42
pubmed: 23512250
Int J Med Sci. 2016 Feb 03;13(2):133-8
pubmed: 26941572
PLoS Genet. 2013 Jun;9(6):e1003566
pubmed: 23785302
J Chin Med Assoc. 2019 Jul;82(7):562-567
pubmed: 31274788
Blood. 2019 Feb 14;133(7):724-729
pubmed: 30510082
Leuk Lymphoma. 2010 Oct;51(10):1870-4
pubmed: 20919861
Int J Cancer. 2008 Oct 1;123(7):1499-507
pubmed: 18646185
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
JNCI Cancer Spectr. 2019 Mar;3(1):pkz007
pubmed: 30984908
Gene. 2013 Jul 25;524(2):203-7
pubmed: 23608171
Int J Cancer. 1983 Dec 15;32(6):703-16
pubmed: 6317578
Cancer. 2008 Jan 15;112(2):416-32
pubmed: 18074355
Leuk Res. 2002 Mar;26(3):261-9
pubmed: 11792415
Cancer Sci. 2018 Feb;109(2):422-434
pubmed: 29178401
Pediatr Blood Cancer. 2019 Jun;66(6):e27620
pubmed: 30815990
Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):987-95
pubmed: 17317646
Leukemia. 2010 Apr;24(4):894-6
pubmed: 20054350
Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):140-5
pubmed: 24200646
Cancer Causes Control. 2008 Apr;19(3):227-56
pubmed: 18066673
Sci Rep. 2018 Jan 11;8(1):548
pubmed: 29323237
Epidemiology. 1990 Jan;1(1):43-6
pubmed: 2081237
Br J Cancer. 2001 Aug 3;85(3):350-6
pubmed: 11487264
Cancer. 2007 May 15;109(10):2100-8
pubmed: 17385214
Gut Liver. 2016 May 23;10(3):332-9
pubmed: 27114433